Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions
EuroIntervention · 2023
DOI: 10.4244/eij-d-22-00609 ↗Kurz gefasst
Fachartikel in der Zeitschrift EuroIntervention, 2023. Verfasst von Anna K Krawisz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, U…. Hauptthemen laut MEDLINE: Peripheral Arterial Disease, Endovascular Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
BACKGROUND: The use of atherectomy during peripheral endovascular interventions (PVI) has increased dramatically, but data regarding its safety and effectiveness are lacking.
Aims
This study sought to determine the long-term safety of atherectomy in contemporary practice.
Methods
Medicare fee-for-service beneficiaries who underwent femoropopliteal artery PVI from 2015-2018 were identified in a 100% sample of inpatient, outpatient, and carrier file data using procedural claims codes. The primary exposure was the use of atherectomy. Inverse probability of treatment weighting was used to adjust for measured differences in patient populations. Kaplan-Meier methods and multivariable Cox proportional hazards regression were used to compare outcomes.
Results
Among 168,553 patients who underwent PVI, 59,142 (35.1%) underwent atherectomy. The mean patient age was 77.0±7.6 years, 44.9% were female, 81.9% were white, and 46.7% had chronic limb-threatening ischaemia. Over a median follow-up time of 993 days (interquartile range 319-1,377 days), atherectomy use was associated with no difference in the risk of either the composite endpoint of death and amputation (adjusted hazard ratio [aHR] 0.99, 95% confidence interval [CI]: 0.97-1.01; p=0.19) or of major adverse limb events (aHR 1.02, 95% CI: 0.99-1.05; p=0.26). Patients who underwent atherectomy had a modest reduction in the risk of subsequently undergoing amputation or surgical revascularisation (aHR 0.92, 95% CI: 0.90-0.94; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Medicine, Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Harvard Medical School, Boston, MA, USA.
- Division of Cardiology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Division of Cardiology, Department of Medicine, Duke University Health System, Durham, NC, USA.
- Division of Vascular and Endovascular Surgery, University of California San Francisco, San Francisco, CA, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Krawisz, A. K., Raja, A., Jones, W. S., Schneider, P., Shen, C., Schermerhorn, M., & Secemsky, E. A. (2023). Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions. EuroIntervention. https://doi.org/10.4244/eij-d-22-00609
Vancouver
Krawisz AK, Raja A, Jones WS, Schneider P, Shen C, Schermerhorn M, et al. Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions. EuroIntervention. 2023. doi:10.4244/eij-d-22-00609
BibTeX
@article{Krawisz2023,
author = {Krawisz, Anna K and Raja, Aishwarya and Jones, W Schuyler and Schneider, Peter and Shen, Changyu and Schermerhorn, Marc and Secemsky, Eric A},
title = {Long-term outcomes of peripheral atherectomy for femoropopliteal endovascular interventions},
journal = {EuroIntervention},
year = {2023},
doi = {10.4244/eij-d-22-00609}
}
EUVIMED